Cleared Traditional

K190232 - Synapse PACS

K190232 is the FDA 510(k) clearance for Synapse PACS by Fujifilm Corporation. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K190232 · Fujifilm Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
48d
Days
Class 2
Risk

K190232 is an FDA 510(k) clearance for the Synapse PACS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Corporation (Minato-Ku, Tokyo, JP). The FDA issued a Cleared decision on March 26, 2019 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Corporation devices

Submission Details

510(k) Number K190232 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2019
Decision Date March 26, 2019
Days to Decision 48 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 107d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Fujifilm Medical Systems U.S.A, Inc.
Senita Sims

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1096
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K190232.
DBSWIN and VISTAEASY Imaging Software
K190629 · Durr Dental SE · Apr 2019
Thoracic VCAR with GSI Pulmonary Perfusion
K183210 · GE Medical Systems SCS · Mar 2019
Mimics Medical
K183105 · Materialise NV · Mar 2019
uWS-MR
K183164 · Shanghai United Imaging Healthcare Co., Ltd. · Mar 2019
SIS Software version 3.3.0
K183019 · Surgical Information Sciences, Inc. · Mar 2019
MIM on Linux
K190379 · Mim Software, Inc. · Mar 2019